Warfarin Potassium

CHEMBL1200772 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
346.4 g/mol
LogP
Phase
4

A potassium salt form of warfarin with the same therapeutic properties. This anticoagulant (blood thinner) medication is used to prevent and treat blood clots, including those in deep veins (DVT), the lungs (pulmonary embolism), and to reduce the risk of stroke in patients with atrial fibrillation or artificial heart valves.

Masse moléculaire

346,4000 g/mol

TPSA

66,40 Ų

Aires thérapeutiques

Mécanisme d'action

Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Inhibits vitamin K epoxide reductase complex.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[K+]

InChI

InChI=1S/C19H16O4.K/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22;/h2-10,15,21H,11H2,1H3;/q;+1/p-1

Molecular Formula

C19H15KO4

HBD / HBA

- / 4

Liaisons Rotatives

4

Atomes Lourds

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A potassium salt form of warfarin with the same therapeutic properties. This anticoagulant (blood thinner) medication is used to prevent and treat blood clots, including those in deep veins (DVT), the lungs (pulmonary embolism), and to reduce the risk of stroke in patients with atrial fibrillation or artificial heart valves.

Inhibits vitamin K epoxide reductase complex.

Yes, Warfarin Potassium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200772. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23706212. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.